BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2005
View Archived Issues
AstraZeneca: second quarter highlights
Read More
NBI-59159: Novel EAAT3 preferring inhibitor from Wyeth
Read More
New data on the efficacy of sitaxsentan in PAH
Read More
A-778193 reduced food intake and body weight via GHS-R antagonism
Read More
MicroIslet and Scripps Research Institute extend diabetes collaboration
Read More
Epitan obtains ethics approval for phase II study of EPT-1647 for PMLE
Read More
Encouraging outcomes for pilot study of Aerosurf delivered via nasal CPAP
Read More
In vitro and in vivo data on novel HIV integrase inhibitor
Read More
Accera receives approval for Ketasyn extension study
Read More
ImClone to use Medarex's UltiMAb system to develop human antibody products
Read More
Zonagen awards contracts for studies of Proellex and Androxal
Read More
Daiichi and GE Healthcare team up on non-nuclear contrast media
Read More
New insulin secretagogues for diabetes reported in recent Takeda patent
Read More
Recent patents cover novel therapeutics for anxiety, depression, etc.
Read More
Novel therapeutics for cardiovascular diseases reported
Read More
Ularitide has beneficial clinical effects in decompensated heart failure patients
Read More
BL-1020 targets GABA hypoactivity and dopamine overactivity for schizophrenia
Read More
Neuronal Kv7 channels: new targets for anxiolytics
Read More
New DPP-IV inhibitor highlighted as a therapeutic candidate for type 2 diabetes
Read More
New clinical evidence supports using oral insulin spray to improve glycemic control in diabetics
Read More
Priority review for Pegasys plus ribavirin in Japan
Read More
BXL-628 demonstrates efficacy in experimental autoimmune prostatitis
Read More
Nonapprovable letter for lasofoxifene in prevention of osteoporosis
Read More
Aromasin approved in Europe for adjuvant treatment of early breast cancer
Read More
Eisai submits NDA for antiepileptic agent rufinamide
Read More
ODAC recommends approval of Tarceva for pancreatic cancer
Read More
FDA committee does not recommend Xinlay
Read More
Antioxidant L-2264 ameliorates metabolic impairment in rats with insulin resistance
Read More
Data on quadrivalent human papillomavirus vaccine accumulate
Read More
